High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology
NCT04940468 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2026-04-07
Summary
The primary objective of the study is to determine whether dietary intervention to increase fiber and decrease fat reduces C. difficile infection recurrence in a cohort of oncology patients.
Conditions
- Leukemia, Lymphocytic, Acute
- Leukemia, Myeloid, Acute
- Lymphoma
- Clostridium Difficile Infection
Interventions
- OTHER
-
Diet Intervention
The dietary fiber intake target will be 19 g/d for ages 9-18 and females age 19 and older and 23g/d for males age 19 and older.
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
National Institute of Allergy and Infectious Diseases (NIAID)
collaborator NIH -
University of Colorado, Denver
lead OTHER
Principal Investigators
-
Catherine Lozupone · University of Colorado, Denver
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 9 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-10-21
- Primary Completion
- 2025-07-02
- Completion
- 2026-01-12
Countries
- United States
Study Locations
More Related Trials
-
Ursodeoxycholic Acid in C. Difficile Infection
NCT05526807 ·Status: TERMINATED ·Phase: NA
-
C Difficile Near-patient Diagnostics
NCT03857464 ·Status: COMPLETED ·Phase: NA
-
Natural History of Clostridioides Difficile Infection
NCT04801862 ·Status: RECRUITING
-
The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection
NCT04668014 ·Status: COMPLETED
-
Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection
NCT01259726 ·Status: COMPLETED ·Phase: PHASE2
-
Bezlotoxumab Efficacy and Tolerability in Cancer Patient
NCT04415918 ·Status: UNKNOWN ·Phase: PHASE4
-
Small Bowel Transit Time in Clostridium Difficile Colitis
NCT01309750 ·Status: TERMINATED
-
FMT Delivered by Capsule Versus Colonoscopy for Recurrent C. Diff
NCT02254811 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI)
NCT03298048 ·Status: TERMINATED ·Phase: PHASE2
-
Fecal Bacterial Flora in Clostridium Difficile-Associated Diarrhea
NCT00304876 ·Status: COMPLETED
-
Fecal Microbiota Transplant by Oral Capsules With Lactobacilli for Recurrent Clostridium Difficile Infection
NCT03804736 ·Status: UNKNOWN ·Phase: NA
-
Early FMT for C.Difficile
NCT02465463 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Host Immune Response to Clostridium Difficile Infection (ICD)
NCT02440438 ·Status: COMPLETED ·Phase: NA
-
Networks of Bacterium-Metabolite Interactions in the Small Intestine
NCT04978077 ·Status: TERMINATED ·Phase: NA
-
Freeze-dried, Capsulized FMT for RCDI
NCT02399618 ·Status: UNKNOWN ·Phase: PHASE1
-
Addition of Lactobacillus to Metronidazole in Treatment of CDAD
NCT00304863 ·Status: WITHDRAWN ·Phase: PHASE4
-
Fidaxomicin to Prevent Clostridium Difficile Colonization
NCT01552668 ·Status: WITHDRAWN ·Phase: PHASE4
-
Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection
NCT03806803 ·Status: COMPLETED ·Phase: PHASE2
-
Fecal Transplant for Relapsing C. Difficile Infection
NCT01703494 ·Status: UNKNOWN ·Phase: PHASE2
-
PROSPECTIVE STUDY OF PREDISPOSING FACTORS OF REFRACTARY Clostridium Difficile INFECTION. INFLUENCE OF THE GUT MICROBIOMA
NCT04259931 ·Status: UNKNOWN
-
Evaluation of the Cost of a Nosocomial Infection With Clostridium Difficile
NCT03025672 ·Status: COMPLETED
-
Primary or Recurrent Clostridioides Difficile Infection Treatment With Capsules of Lyophilised Faecal Microbiota vs Fidaxomicin
NCT05201079 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Vancomycin to Prevent Recurrent C Difficile Infection With Antibiotics
NCT03466502 ·Status: COMPLETED ·Phase: PHASE4
-
Clostridium Difficile Infection (CDI) in Hematologic Patients.
NCT03964844 ·Status: UNKNOWN
-
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
NCT02127398 ·Status: RECRUITING ·Phase: PHASE2